| Oct 29 |
New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy
|
| Oct 10 |
Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024
|
| Oct 1 |
Breaking Down Nevro: 10 Analysts Share Their Views
|
| Sep 26 |
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
|
| Sep 25 |
NVRO Stock May Gain on the FDA Approval of Its HFX AdaptivAI Platform
|
| Sep 25 |
Nevro obtains FDA approval for AI-based spinal cord stimulation system
|
| Sep 12 |
Vanguard Group Inc's Strategic Reduction in Nevro Corp Holdings
|
| Aug 28 |
Nevro to Present at Wells Fargo 2024 Healthcare Conference
|
| Aug 9 |
Citi upgrades Nevro to neutral following sell-off
|
| Aug 9 |
Nevro: Not Having My Back
|
